去铁胺 deferoxamine ; DFO ; Desferrioxamine ; Desferal
去铁酮片 DeferiproneTablets ; De ; Defe ; Deferiprone Table
注射用甲磺酸去铁胺 Desferrioxamine Mesilate for Injection ; Desferrioxamine messylate ; Desferrioxa
去铁酮 Deferiprone ; Deferiprone Tablets ; Hydroxy-1,2-dimethyl-4-pyridone ; DFP
去铁斯若 Deferasirox
去铁铁朊 apoferritin
甲磺酸去铁胺 Deferoxamine mesylate ; desferrioxamine mesylate ; DFO ; Deferoxamine
甲磺酸去铁敏 deferoxamine mesylate
去铁胺甲磺酸酯 Deferoxamine Mesylate
结果 与强铁螯合剂去铁胺相比 ，瑞香素具有中度的铁螯合能力。
Results Daphnetin exhibited a modest iron-chelating ability compared with the powerful iron-chelator desferrioxamine B.
作为传统的铁螯合剂，去铁酮和去铁胺因其不良反应或治疗依从性差等问题无法满足临床治疗需要。
Traditionally, iron chelating agents include deferiprone and deferoxamine, but they are not the satisfied treatment choice due to their side effects or non-convenience for administration.
由于铁可导致DA神经元死亡，因此铁含量的增加可能是DA含量减少的原因之一，甲磺酸去铁胺具有保护DA神经元的作用。
Elevation of iron content in SN is one of the mechanisms responsible for the reduction of DA content. Desferrioxamine mesylate may exert a protective action on dopaminergic neurons.
应用推荐